107
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Failure of Epigenetic Combination Therapy for Cancer and what it Might be Telling us about DNA Methylation Inhibitors

&
Pages 9-12 | Received 04 Sep 2015, Accepted 18 Sep 2015, Published online: 23 Dec 2015
 

Disclaimer

The statements and opinions made in this article are that of AS Yang and do not reflect the opinion of Spectrum Pharmaceutical Inc.

Financial & competing interests disclosure

AS Yang is a full-time employee of Spectrum Pharmaceutical Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

AS Yang is a full-time employee of Spectrum Pharmaceutical Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.